Exchange: NYSE·Updated 10:45 AM EDT
ANVS logo

ANVSAnnovis Bio Inc

$1.73
$0.02
(1.14%)
Today
Reported EarningsMay 15
Mkt Cap$74.45M
Vol84,552.00
News
all
press releases
Annovis Bio, Inc. (NYSE:ANVS) Sees Significant Increase in Short Interest
Annovis Bio, Inc. (NYSE:ANVS - Get Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totaling 4,760,673 shares, a growth of...
MarketBeat
More News
Traders Buy Large Volume of Annovis Bio Call Options (NYSE:ANVS)
Annovis Bio, Inc. (NYSE:ANVS - Get Free Report) was the target of unusually large options trading activity on Thursday. Traders bought 3,361 call options on the stock. This represents an increase of...
MarketBeat
Insider Buying: Annovis Bio (NYSE:ANVS) Director Acquires 713,800 Shares of Stock
Annovis Bio, Inc. (NYSE:ANVS - Get Free Report) Director Michael Hoffman bought 713,800 shares of the business's stock in a transaction dated Thursday, April 2nd. The stock was acquired at an average...
MarketBeat
Annovis Bio (NYSE:ANVS) Releases Earnings Results, Misses Expectations By $0.08 EPS
Annovis Bio (NYSE:ANVS - Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of...
MarketBeat
Annovis Bio (ANVS) Projected to Post Quarterly Earnings on Friday
Annovis Bio (NYSE:ANVS) will be releasing its Q4 2025 earnings before the market opens on Friday, March 20. (View Earnings Report at...
MarketBeat
Annovis Bio (NYSE:ANVS) Stock Price Down 8.5% - What's Next?
Annovis Bio (NYSE:ANVS) Stock Price Down 8.5% - Here's What Happened...
MarketBeat
Annovis Bio (NYSE:ANVS) Shares Down 1% - Here's Why
Annovis Bio (NYSE:ANVS) Shares Down 1% - Should You Sell...
MarketBeat
Annovis Bio, Inc. (NYSE:ANVS) Receives Average Recommendation of "Hold" from Analysts
Annovis Bio, Inc. (NYSE:ANVS - Get Free Report) has been assigned a consensus recommendation of "Hold" from the five brokerages that are currently covering the stock, MarketBeat Ratings reports. One...
MarketBeat
Annovis Bio, Inc. (NYSE:ANVS) Given Consensus Rating of "Hold" by Analysts
Shares of Annovis Bio, Inc. (NYSE:ANVS - Get Free Report) have been assigned an average recommendation of "Hold" from the five brokerages that are currently covering the firm, MarketBeat Ratings...
MarketBeat
Insider Buying: Annovis Bio (NYSE:ANVS) Director Buys 45,000 Shares of Stock
Annovis Bio, Inc. (NYSE:ANVS - Get Free Report) Director Michael Hoffman bought 45,000 shares of the business's stock in a transaction dated Monday, December 8th. The stock was bought at an average...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.